Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.2540
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.99K CAD in the quarter ending June 30, 2025, with 1.77% growth. This brings the company's revenue in the last twelve months to 154.90K, down -4.26% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.
Revenue (ttm)
154.90K CAD
Revenue Growth
-4.26%
P/S Ratio
221.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
25.15M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 154.22K | -9.00K | -5.52% |
Mar 31, 2024 | 163.22K | 9.73K | 6.34% |
Mar 31, 2023 | 153.49K | 109.56K | 249.38% |
Mar 31, 2022 | 43.93K | - | - |
Mar 31, 2021 | - | - | - |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tian'an Technology Group | 2.12M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Biomark Diagnostics News
- 5 weeks ago - BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership - Newsfile Corp
- 6 weeks ago - BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships - Newsfile Corp
- 7 weeks ago - BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026 - Newsfile Corp
- 4 months ago - BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology - Newsfile Corp
- 4 months ago - BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test - Newsfile Corp
- 4 months ago - BioMark Diagnostics Announces Uplisting to OTCQB Venture Market - Newsfile Corp
- 6 months ago - BioMark Announces the Final Closing of Oversubscribed Private Placement - Newsfile Corp
- 7 months ago - BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 - Newsfile Corp